Table of Contents Table of Contents 2 List of Tables 5 List of Figures 5 SK Biopharmaceuticals Co., Ltd. Snapshot 6 SK Biopharmaceuticals Co., Ltd. Overview 6 Key Information 6 Key Facts 6 SK Biopharmaceuticals Co., Ltd. - Research and Development Overview 7 Key Therapeutic Areas 7 SK Biopharmaceuticals Co., Ltd. - Pipeline Review 10 Pipeline Products by Stage of Development 10 Pipeline Products - Monotherapy 11 SK Biopharmaceuticals Co., Ltd. - Pipeline Products Glance 12 SK Biopharmaceuticals Co., Ltd. - Late Stage Pipeline Products 12 Phase III Products/Combination Treatment Modalities 12 SK Biopharmaceuticals Co., Ltd. - Clinical Stage Pipeline Products 13 Phase II Products/Combination Treatment Modalities 13 Phase I Products/Combination Treatment Modalities 14 SK Biopharmaceuticals Co., Ltd. - Early Stage Pipeline Products 15 IND/CTA Filed Products/Combination Treatment Modalities 15 Preclinical Products/Combination Treatment Modalities 16 Discovery Products/Combination Treatment Modalities 17 SK Biopharmaceuticals Co., Ltd. - Drug Profiles 18 SKL-N05 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 YKP-3089 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 relenopride hydrochloride 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 carisbamate 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 SKL-15508 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 SKL-A4R 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 SKL-PD 27 Product Description 27 Mechanism of Action 27 R&D Progress 27 SKL-PSY 28 Product Description 28 Mechanism of Action 28 R&D Progress 28 N-2 29 Product Description 29 Mechanism of Action 29 R&D Progress 29 SKL-16036 30 Product Description 30 Mechanism of Action 30 R&D Progress 30 SKL-DEP 31 Product Description 31 Mechanism of Action 31 R&D Progress 31 SKL-G 32 Product Description 32 Mechanism of Action 32 R&D Progress 32 Small Molecule for Multiple Sclerosis 33 Product Description 33 Mechanism of Action 33 R&D Progress 33 Small Molecule for Neuropathic Pain 34 Product Description 34 Mechanism of Action 34 R&D Progress 34 Small Molecule for Tauopathies and Alzheimer's Disease 35 Product Description 35 Mechanism of Action 35 R&D Progress 35 Small Molecule to Inhibit TDP-43 for Amyotrophic Lateral Sclerosis 36 Product Description 36 Mechanism of Action 36 R&D Progress 36 SK Biopharmaceuticals Co., Ltd. - Pipeline Analysis 37 SK Biopharmaceuticals Co., Ltd. - Pipeline Products by Target 37 SK Biopharmaceuticals Co., Ltd. - Pipeline Products by Route of Administration 39 SK Biopharmaceuticals Co., Ltd. - Pipeline Products by Molecule Type 40 SK Biopharmaceuticals Co., Ltd. - Pipeline Products by Mechanism of Action 41 SK Biopharmaceuticals Co., Ltd. - Recent Pipeline Updates 42 SK Biopharmaceuticals Co., Ltd. - Dormant Projects 45 SK Biopharmaceuticals Co., Ltd. - Discontinued Pipeline Products 46 Discontinued Pipeline Product Profiles 46 carisbamate 46 SK Biopharmaceuticals Co., Ltd. - Locations And Subsidiaries 47 Head Office 47 Other Locations & Subsidiaries 47 Appendix 48 Methodology 48 Coverage 48 Secondary Research 48 Primary Research 48 Expert Panel Validation 48 Contact Us 48 Disclaimer 49

List of Tables SK Biopharmaceuticals Co., Ltd., Key Information 6 SK Biopharmaceuticals Co., Ltd., Key Facts 6 SK Biopharmaceuticals Co., Ltd. - Pipeline by Indication, 2016 8 SK Biopharmaceuticals Co., Ltd. - Pipeline by Stage of Development, 2016 10 SK Biopharmaceuticals Co., Ltd. - Monotherapy Products in Pipeline, 2016 11 SK Biopharmaceuticals Co., Ltd. - Phase III, 2016 12 SK Biopharmaceuticals Co., Ltd. - Phase II, 2016 13 SK Biopharmaceuticals Co., Ltd. - Phase I, 2016 14 SK Biopharmaceuticals Co., Ltd. - IND/CTA Filed, 2016 15 SK Biopharmaceuticals Co., Ltd. - Preclinical, 2016 16 SK Biopharmaceuticals Co., Ltd. - Discovery, 2016 17 SK Biopharmaceuticals Co., Ltd. - Pipeline by Target, 2016 37 SK Biopharmaceuticals Co., Ltd. - Pipeline by Route of Administration, 2016 39 SK Biopharmaceuticals Co., Ltd. - Pipeline by Molecule Type, 2016 40 SK Biopharmaceuticals Co., Ltd. - Pipeline Products by Mechanism of Action, 2016 41 SK Biopharmaceuticals Co., Ltd. - Recent Pipeline Updates, 2016 42 SK Biopharmaceuticals Co., Ltd. - Dormant Developmental Projects,2016 45 SK Biopharmaceuticals Co., Ltd. - Discontinued Pipeline Products, 2016 46 SK Biopharmaceuticals Co., Ltd., Other Locations 47 SK Biopharmaceuticals Co., Ltd., Subsidiaries 47 List of Figures SK Biopharmaceuticals Co., Ltd. - Pipeline by Top 10 Indication, 2016 8 SK Biopharmaceuticals Co., Ltd. - Pipeline by Stage of Development, 2016 10 SK Biopharmaceuticals Co., Ltd. - Monotherapy Products in Pipeline, 2016 11 SK Biopharmaceuticals Co., Ltd. - Pipeline by Top 10 Target, 2016 37 SK Biopharmaceuticals Co., Ltd. - Pipeline by Route of Administration, 2016 39 SK Biopharmaceuticals Co., Ltd. - Pipeline by Molecule Type, 2016 40 SK Biopharmaceuticals Co., Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2016 41